Investigation of the pharmacokinetic drug-drug interaction between oral formoterol and oral roflumilast -A randomized, open, 2-period- study

*Please Note* The Study you are attempting to view was acquired from Takeda by AstraZeneca and was disclosed initially by Takeda per their Transparency Policies. More information regarding this study may be available by contacting [email protected].

An open-label, randomized, two-period-crossover study in 24 healthy subjects.